The Invisible Giant Amongst Us: Genetic Tests Used in the Early Identification of Respiratory Pathogens — COVID-19 and Beyond

Wednesday, December 7, 2022

8:00 AM – 9:15 AM

Location: Mandalay Bay South Convention Center, Lagoon F, Level 2

CE Credits: 1.25 contact hours

Activity #: 0204-0000-22-310-L04-P
Activity #: 0204-0000-22-310-L04-T
Activity Type: Application-based
Target Audience: Pharmacist, Pharmacy Technician

Learning Objectives:

Given a case, analyze the current methodologies used in identifying COVID-19.
Given a case, assess the medical benefits of rapidly identifying respiratory pathogens in patients with respiratory infections.
Given a case, evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers.
Given a case, summarize the current literature on the use of novel genetic tests which can be used in rapid identification and susceptibility of respiratory pathogens.

Program Chair(s)

Edward E. Grace, PharmD, AAHIVP, BCIDP, FIDSA

Specialty infectious Diseases Clinical Pharmacist
Sovereign Medical Consulting, Fort Wayne, IN

Moderator(s)

Edward E. Grace, PharmD, AAHIVP, BCIDP, FIDSA

Specialty infectious Diseases Clinical Pharmacist
Sovereign Medical Consulting, Fort Wayne, IN

Faculty Member(s)

Christopher Farrell, PhD

Professor
Presbyterian College
Edward E. Grace, PharmD, AAHIVP, BCIDP, FIDSA

Specialty infectious Diseases Clinical Pharmacist
Sovereign Medical Consulting, Fort Wayne, IN